Learn what manufacturing changes trigger FDA re-evaluation for generic drugs, how the approval process works, and how new programs are speeding up approvals for U.S.-made generics.
Adverse drug events cause over a million emergency visits each year in the U.S.-many are preventable. Learn what they are, which drugs are most dangerous, and how you can protect yourself.
Most dental procedures are safe while on blood thinners. Stopping your medication can be riskier than keeping it. Learn which procedures are safe, how to manage bleeding, and what to tell your dentist.
Colesevelam helps lower cholesterol and manage diabetes, but constipation and bloating are common side effects. Learn how to prevent and manage them with proven strategies, dosing tips, and when to seek help.
Patients often hesitate to take generic medications due to misconceptions about effectiveness and appearance. Learn proven communication strategies pharmacists can use to build trust, explain bioequivalence, and improve adherence with simple, evidence-based techniques.
Corticosteroids alone rarely cause gastric ulcers, but combining them with NSAIDs raises risk dramatically. Learn who truly needs PPIs, what symptoms to watch for, and why routine prophylaxis may do more harm than good.
Metronidazole and alcohol don't cause a dangerous disulfiram-like reaction as once believed. New evidence shows no acetaldehyde buildup - here's what really happens and what you should do.
Home health services help seniors manage medications safely at home by organizing doses, preventing errors, and reducing hospital visits. Learn how these services work, who qualifies, and what tools make the biggest difference.
Learn how to access and use the FDA's FAERS database for drug safety monitoring. Understand what the data shows, what it doesn't, and how to avoid common mistakes when interpreting adverse event reports.
The EU's generic drug approval system is complex, with four pathways, national variations, and major 2025 reforms. Learn how regulatory changes are speeding up access, cutting delays, and reshaping market competition across Europe.
